Condition: Critical Illness · Delirium in the Intensive Care Unit · Sleep Quality · Sponsor: Scripps Health
The goal of this observational study is to learn if there are potential digital and plasma-based biomarkers that could help detect, predict, and prognosticate delirium in older adult patients who are admitted to the intensive care unit (ICU). The main question DELTA aims to answer is: Can digital biometrics predict and detect delirium in older adult ICU patients? Do biomarkers of neurodegeneration fluctuate in ICU patients in such a way that delrium could potentially be predicted? Participants admitted o the ICU will wear a digital device to collect biometric data and will have serial plasma samples collected during ICU admission and patients will be also assessed for delirium daily by study staff.
This description comes directly from the study's public registry record.
Stuti Jaiswal, MD, PhD · 858-554-9100 · jaiswal.stuti@scrippshealth.org
Always discuss trial participation with your own doctor first.
| Scripps Green Hospital | La Jolla, California, United States | Not Yet Recruiting |
| Scripps Memorial La Jolla Hospital | San Diego, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07694206